DeepRare, a multi-agent AI system, achieves 10% higher accuracy than expert physicians in diagnosing rare diseases, potentially reducing diagnostic delays and transforming clinical practice with trans...
A new AI system, DeepRare, demonstrates superior accuracy in diagnosing rare diseases using real-time data and self-reflective reasoning, as detailed in a 2026 Nature study, with potential to reduce d...
Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
Artificial intelligence is transforming healthcare by enabling bespoke treatments for rare diseases, reducing drug development costs, and raising ethical questions, as shown in recent studies and regu...
Exploring how AI and genomics are transforming personalized medicine, from predicting disease risks to optimizing treatments and addressing ethical challenges. AI and genomics are reshaping personaliz...
